Neogen Corp
Neogen Corp (NEOG) is listed on NASDAQ and classified in Medical Devices, part of the Healthcare sector. It is headquartered in Lansing, United States and has 2,636 employees. The company is worth $2.62B. Revenue was $870.4M in fiscal 2026, down 2.7% from the year before. It reported a net loss of $7.9M. The share price is 16.0% below its 52-week high of $14.26. 3 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Cliff Asness (AQR Capital Management), at $4.49M. In that quarter, 1 of them opened or added to the position and 1 reduced it. Over the last 30 days, company insiders bought $6.03K of its stock on the open market and sold none.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Major managers that reported this stock in their latest 13F.
▼ -70.6% over 5Y.
today you would have $279.13▼ -72.1%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 17 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $11.81 | $6.99 | $12.14 | $20.11 | $15.23 | $45.41 | $39.65 | $32.63 | $28.50 | $30.84 | $24.76 | $21.20 | $18.60 | $17.14 | $11.33 | $7.66 | $10.26 | |
| P/E |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| MRVIMaravai Lifesciences Holdings Inc | $7.07 | — | 5.1x | 0.00% | -33.05% | $2.62B |
| VRDNViridian Therapeutics, Inc.\DE | $22.82 | — | 4.6x | 0.00% | -65.74% | $2.59B |
| AVAHAveanna Healthcare Holdings, Inc. | $12.34 | 9.8x | 9.3x | 0.00% | 198.57% | $2.69B |
| BEAMBeam Therapeutics Inc. |
| 60.9x |
| — |
| — |
| — |
| — |
| 33.8x |
| 79.7x |
| 70.8x |
| 57.2x |
| 47.1x |
| 71.7x |
| 68.8x |
| 62.8x |
| 65.3x |
| 60.9x |
| 48.7x |
| 31.9x |
| 54.0x |
| P/S | 7.4x | 3.0x | 1.7x | 2.8x | 5.3x | 3.1x | 10.4x | 10.0x | 8.2x | 7.4x | 8.7x | 7.7x | 7.4x | 7.4x | 7.9x | 5.8x | 4.1x | 6.7x |
| P/B | 5.3x | 1.2x | 0.7x | 0.8x | 1.4x | 1.9x | 5.8x | 5.8x | 5.3x | 5.3x | 6.7x | 6.1x | 6.0x | 5.9x | 6.4x | 4.9x | 3.8x | 6.2x |
| EPS | -$0.04 | -$5.03 | -$0.04 | -$0.12 | $0.45 | $0.57 | $0.56 | $0.57 | $0.61 | $0.43 | $0.36 | $0.34 | $0.29 | $0.28 | $0.23 | $0.24 | $0.19 |
| Profit margin | 12.11% | -0.91% | -122.05% | -1.02% | -2.78% | 9.16% | 13.00% | 14.22% | 14.53% | 15.87% | 12.11% | 11.38% | 11.84% | 11.38% | 13.10% | 12.23% | 13.23% | 12.47% |
| ROE | 9.19% | -0.38% | -52.72% | -0.30% | -0.73% | 5.44% | 7.24% | 8.20% | 9.43% | 11.27% | 9.29% | 9.05% | 9.55% | 9.19% | 10.53% | 10.29% | 12.11% | 11.44% |
Median of the years shown; P/E years above 200x are left out.
| $24.56 |
| — |
| 2.3x |
| 0.00% |
| -8.18% |
| $2.54B |
| NAMSNewAmsterdam Pharma Co N.V. | $21.58 | — | 4.0x | 0.00% | -36.81% | $2.52B |
| CLOVClover Health Investments Corp | $4.73 | — | 6.7x | 0.00% | -5.10% | $2.51B |